Definitely. It is almost a certainty that the stock will move dramatically one way or the other. In fact, beware of a big move on 7/24 when the FDA will release its dossier on Rexista for the meeting on the 26th. Many investors are inexperienced with Ad Com hearings and the dossier is usually filled with info that sounds like the FDA is really concerned about the drug. Actually, they are just trying to present the most difficult issues the drug presents to the panel of experts and are not likely anywhere near as negative as it might sound by reading the dossier. So, I would not be surprised if the stock got rocked a little on the 24th. But I do expect a pretty favorable meeting on the 26th and the stock could really jump if I am right about that.